Summary#
This bill would make the shingles vaccine Shingrix a covered service under Nova Scotia’s public health plan for residents age 50 and older. The province would pay for both the vaccine and the act of giving the shot, as long as money is approved in the budget.
- Makes Shingrix an “insured” service for Nova Scotia residents who are 50 or older.
- Covers both the vaccine itself and the administration (the shot).
- Applies even if current fee rules or regulations would not normally cover it.
- Funding depends on money approved by the Legislature.
What it means for you#
- Residents age 50 and older: You could get the Shingrix vaccine with no out-of-pocket cost at the time of vaccination, once the law takes effect and funding is in place. Shingrix is given in two doses, so you would likely need two appointments.
- Adults under 50: No change. You would still pay for Shingrix yourself if you choose to get it, unless other programs apply.
- People on fixed incomes: This removes a major cost barrier for a vaccine that can be expensive when paid out of pocket.
- Caregivers and families: Lower risk that older family members will get shingles and related nerve pain.
- Health-care providers (doctors, pharmacists, clinics): You would be able to bill the provincial plan for providing and administering Shingrix to eligible patients, once funding is approved.
Expenses#
No publicly available information.
Proponents' View#
- Expands access to a proven vaccine that helps prevent shingles and long-lasting nerve pain, which are more common as people age.
- Reduces cost barriers for older adults, many of whom live on fixed incomes.
- May lower pressure on the health system by preventing doctor visits, emergency visits, and treatments linked to shingles complications.
- Clear age rule (50+) makes it simple for providers to check eligibility and offer the vaccine.
- Aligns with a prevention-first approach to health care.
Opponents' View#
- Could be costly to cover an expensive, two-dose vaccine for everyone 50 and over; funds might be needed for other health priorities.
- A broad age cutoff may pay for vaccines for people at relatively lower risk, rather than targeting the highest-risk groups.
- Coverage depends on yearly budget approval, which could delay rollout or create uncertainty.
- Large-scale demand could strain supply and appointment slots at pharmacies and clinics.
- People under 50 with health risks are not covered, which some may see as an unfair gap.